These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35780051)

  • 1. A new survival model based on ferroptosis-related genes (FRGS) for prognostic prediction in bladder cancer.
    Yang Y; Hu H; Chen L; Zhang H; Yang J
    Actas Urol Esp (Engl Ed); 2022 Oct; 46(8):494-503. PubMed ID: 35780051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment.
    Ma J; Hu J; Zhao L; Wu Z; Li R; Deng W
    BMC Urol; 2024 Jan; 24(1):6. PubMed ID: 38172792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel Ferroptosis-Related Gene Signature for Prediction of Prognosis in Bladder Urothelial Carcinoma.
    Shi X; Zhou X; Zhang L; Yue C; Gao S; Cheng J; Zuo L; Zhang L
    Bladder Cancer; 2022; 8(1):19-34. PubMed ID: 38994521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer.
    Liu X; Qiu Z; Zhang X; Su Z; Yi R; Zou D; Xie C; Jin N; Long W; Liu X
    Environ Toxicol; 2024 Feb; 39(2):680-694. PubMed ID: 37647346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
    Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
    Front Oncol; 2021; 11():726486. PubMed ID: 34966666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
    Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
    Front Oncol; 2021; 11():686044. PubMed ID: 34422642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
    Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
    Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
    Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
    Front Oncol; 2021; 11():730716. PubMed ID: 34557413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
    Zhang M; Zhang X; Yu M; Zhang W; Zhang D; Zeng S; Wang X; Hu X
    Front Oncol; 2021; 11():698856. PubMed ID: 34386423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
    Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y
    PeerJ; 2023; 11():e15284. PubMed ID: 37123010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
    Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
    Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma.
    Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L
    Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancer.
    Zang J; Cui M; Xiao L; Zhang J; Jing R
    Clin Transl Oncol; 2023 Aug; 25(8):2532-2544. PubMed ID: 36995520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transferrin receptor/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer.
    Qin J; Li Z; Su L; Wen X; Tang X; Huang M; Wu J
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133323. PubMed ID: 38908617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
    Liu Z; Du D; Zhang S
    Toxicol Res (Camb); 2024 Feb; 13(1):tfae010. PubMed ID: 38292893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSPA5 Promotes the Proliferation, Metastasis and Regulates Ferroptosis of Bladder Cancer.
    Wang Q; Ke S; Liu Z; Shao H; He M; Guo J
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPDR1 is related to stages and metastasize in bladder cancer and can be used as a prognostic biomarker.
    Yang Y; Zhang H; Liu Z; Zhao F; Liang G
    BMC Urol; 2021 Apr; 21(1):71. PubMed ID: 33902536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.